Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/bromocriptine-induces-marked-locomotor-stimulation-in-dopamine-IKT9V0nFBu
References (13)
-
N. Watzman, H. Barry, W. Kinnard, J. Buckley (1967)
Influence of chlorpromazine on spontaneous activity of mice under various parametric conditions.Archives internationales de pharmacodynamie et de therapie, 165 2
-
O. Jenkins, D. Jackson (1985)
Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in miceNaunyn-Schmiedeberg's Archives of Pharmacology, 331
-
P. Setler, H. Sarau, C. Zirkle, H. Saunders (1978)
The central effects of a novel dopamine agonist.European journal of pharmacology, 50 4
-
H. Corrodi, K. Fuxe, T. Hökfelt, P. Lidbrink, U. Ungerstedt (1973)
Effect of ergot drugs on central catecholamine neurons: Evidence for a stimulation of central dopamine neuronsJournal of Pharmacy and Pharmacology, 25
-
C. Reavill, P. Jenner, C. Marsden (1980)
Metabolite involvement in bromocriptine‐induced circling behaviour in rodentsJournal of Pharmacy and Pharmacology, 32
-
J. Kebabian, D. Calne (1979)
Multiple receptors for dopamineNature, 277
-
J. Lew, F. Hata, T. Ohashi, M. Goldstein (2005)
The interactions of bromocriptine and lergotrile with dopamine and α-adrenergic receptorsJournal of Neural Transmission, 41
-
(1985)
Hypothesis: bromocriptine, in the absence of dopamine agonists such as dopamine and apomorphine, is devoid of behavioural stimulant effects -
O. Jenkins, D. Jackson (1986)
Bromocriptine enhances the behavioural effects of apomorphine and dopamine after systemic or intracerebral injection in ratsNeuropharmacology, 25
-
A. Johnson, D. Loew, J. Vigouret (1976)
STIMULANT PROPERTIES OF BROMOCRIPTINE ON CENTRAL DOPAMINE RECEPTORS IN COMPARISON TO APOMORPHINE, (+)‐AMPHETAMINE AND l‐DOPABritish Journal of Pharmacology, 56
-
P. Green, B. Winer, Donald Brown, K. Michels (1963)
Statistical Principles in Experimental Design -
R. Bailey, D. Jackson (1978)
A pharmacological study of changes in central nervous system receptor responsiveness after long-term dexamphetamine and apomorphine administrationPsychopharmacology, 56
-
K. Fuxe, B. Fredholm, L. Agnati, S. Ogren, B. Everitt, G. Jonsson, J. Gustafsson (1978)
Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders.Pharmacology, 16 Suppl 1
- Publisher
- Springer Journals
- Copyright
- Copyright © 1986 by Springer-Verlag Berlin Heidelberg
- Subject
- Biomedicine; Pharmacology/Toxicology; Psychiatry
- ISSN
- 0033-3158
- eISSN
- 1432-2072
- DOI
- 10.1007/BF00172888
- Publisher site
- See Article on Publisher Site
Abstract
213 90 90 1 1 David M. Jackson Mayko Hashizume Department of Pharmacology The University of Sydney 2006 N.S.W. Australia Abstract In mice pretreated with reserpine plus alphamethyl- p -tyrosine, neither the D-2 selective agonist bromocriptine, nor the D-1 selective agonist SKF38393, produced any measurable increase in locomotion in mice. However, the combination of the two agonists produced a marked and dose-dependent increase in co-ordinated locomotor activity. In mice with their dopamine stores and dopamine synthesis intact, SKF38393 was inactive by itself, but significantly enhanced the stimulant effect produced by bromocriptine. The data suggest that bromocriptine requires concomitant stimulation of D-1 receptors for the full expression of its behavioural stimulant effects.
Journal
Psychopharmacology – Springer Journals
Published: Aug 1, 1986